This review article explores the role of alpha-lipoic acid (ALA) in managing diabetic peripheral neuropathy, highlighting its antioxidant properties and therapeutic potential. ALA reduces oxidative stress, enhances reduced glutathione levels, and protects nerves from hyperglycemia-induced damage. Clinical trials have demonstrated that 600 mg of ALA daily, administered either intravenously or
